/* ]]> */
Associate Professor of Medicine, Vanderbilt University School of Medicine
Vandana Abramson is a medical oncologist at Vanderbilt University School of Medicine. She specializes in breast cancer, with a particular interest in the mechanisms of treatment response and resistance. Her research focuses on phase I/II clinical trials of novel combinations therapies, a topic on which she has published extensively. Dr. Abramson has been a principal investigator on over 30 clinical trials at Vanderbilt and is currently leading several national studies. She has received numerous accolades for her clinical work and research, including the Conquer Cancer Foundation’s Advanced Clinical Research Award in Breast Cancer.
Dr. Abramson received her undergraduate degree in English and Molecular & Cell Biology from the University of California, Berkeley, and her M.D. from the University of Chicago Pritzker School of Medicine. She subsequently completed a residency in Internal Medicine at Brigham and Women’s Hospital/Harvard Medical School, followed by a fellowship in medical oncology at the University of Pennsylvania, where she also obtained a master’s degree in Translational Research. Dr. Abramson is an active member of the American Society of Clinical Oncology.